Showing 1 - 10 of 39,225
We analyze the doping behavior of heterogeneous athletes in an environment of private information. In a n-player strategic game, modeled as an all-pay auction, each athlete has private information about his actual physical ability and choses the amount of performance-enhancing drugs. The use of...
Persistent link: https://www.econbiz.de/10009772194
Persistent link: https://www.econbiz.de/10011999353
Persistent link: https://www.econbiz.de/10011626046
Persistent link: https://www.econbiz.de/10011815023
Persistent link: https://www.econbiz.de/10011914265
Persistent link: https://www.econbiz.de/10011326793
Persistent link: https://www.econbiz.de/10003844289
Persistent link: https://www.econbiz.de/10014474220
We study the spillover effects of prescription drug monitoring programs (PDMPs) on crime, and in the process inform how policies that restrict access to Rx opioids per se within the healthcare system would impact broader non-health domains. In response to the substantial increase in opioid use...
Persistent link: https://www.econbiz.de/10012480628
For almost two decades, Virginia has used risk assessment to justify “alternative” nonprison sentences for eligible drug and property offenders. In Study 1, we examined how frequently alternative sentences actually were imposed. We found that alternative sentences were given to only 42% of...
Persistent link: https://www.econbiz.de/10012864768